-- FutureCeuticals, Inc. today (MOMENCE, Ill., Nov. 6, 2014) announced publication of the results of a successful human clinical study on
FruiteX-B® Calcium Fructoborate, a patented mineral complex.
The double-blind, placebo-controlled study examined the effects of FruiteX-B
with a combination of glucosamine and chondroitin versus glucosamine and
chondroitin alone on joint health and flexibility. Outcome measures included the
widely-used WOMAC and McGill questionnaires, standard indices of joint and flex
comfort.
Over 14 days, subjects in the FruiteX-B, glucosamine, and chondroitin group experienced a 24% improvement in WOMAC scores and a 25% improvement in McGill scores. Subjects taking the glucosamine/chondroitin combination alone did not experience any significant improvements. Statistics were independently reviewed by the Department of Statistics, School of Information and Computer Science, University of California at Irvine.
"This study shows that in the context of the widely used combination of glucosamine and chondroitin, FruiteX-B continues to provide the significant benefits for joint health documented in previous research on this remarkable mineral complex," said Hartley Pond, the company's Vice President of Sales. "The results in the FruiteX-B, glucosamine, and chondroitin group align with previous studies published earlier this year and in 2012. In all instances, FruiteX-B delivered significant, fast-acting improvement that people feel."
"With an advantageous serving size and price, FruiteX-B is capable of delivering the now requisite "take-it, feel-it" experience while enhancing the sustained, slower-onset, long-term relief afforded by the stand-by ingredients," Pond added.
Source: "Journal of Aging Research and Clinical Practice." Published online ahead of print: (http://www.jarcp.com/all-issues.html?article=242)
Article: Short-term efficacy of a combination of glucosamine and chondroitin sulfate compared to a combination of glucosamine, chondroitin sulfate and calcium fructoborate (cfb) on improvement of knee discomfort conditions in healthy subjects. A comparative, double-blind, placebo controlled acute clinical study.
Authors: Zbigniew Pietrzkowski, Michael J. Phelan, Robert Keller, Cynthia Shu, Ruby Argumedo, Tania Reyes-Izquierdo
FruiteX-B® Calcium Fructoborate is manufactured under US Patent #5,962,049 and issued and pending foreign patents and is available exclusively from VDF FutureCeuticals, Inc.
About FutureCeuticals, Inc.FutureCeuticals, Inc. is a vertically integrated functional food ingredient, product development, and bioanalytical research and discovery company with farms and facilities in Illinois, Indiana, Wisconsin, California, and Europe.
Over 14 days, subjects in the FruiteX-B, glucosamine, and chondroitin group experienced a 24% improvement in WOMAC scores and a 25% improvement in McGill scores. Subjects taking the glucosamine/chondroitin combination alone did not experience any significant improvements. Statistics were independently reviewed by the Department of Statistics, School of Information and Computer Science, University of California at Irvine.
"This study shows that in the context of the widely used combination of glucosamine and chondroitin, FruiteX-B continues to provide the significant benefits for joint health documented in previous research on this remarkable mineral complex," said Hartley Pond, the company's Vice President of Sales. "The results in the FruiteX-B, glucosamine, and chondroitin group align with previous studies published earlier this year and in 2012. In all instances, FruiteX-B delivered significant, fast-acting improvement that people feel."
"With an advantageous serving size and price, FruiteX-B is capable of delivering the now requisite "take-it, feel-it" experience while enhancing the sustained, slower-onset, long-term relief afforded by the stand-by ingredients," Pond added.
Source: "Journal of Aging Research and Clinical Practice." Published online ahead of print: (http://www.jarcp.com/all-issues.html?article=242)
Article: Short-term efficacy of a combination of glucosamine and chondroitin sulfate compared to a combination of glucosamine, chondroitin sulfate and calcium fructoborate (cfb) on improvement of knee discomfort conditions in healthy subjects. A comparative, double-blind, placebo controlled acute clinical study.
Authors: Zbigniew Pietrzkowski, Michael J. Phelan, Robert Keller, Cynthia Shu, Ruby Argumedo, Tania Reyes-Izquierdo
FruiteX-B® Calcium Fructoborate is manufactured under US Patent #5,962,049 and issued and pending foreign patents and is available exclusively from VDF FutureCeuticals, Inc.
About FutureCeuticals, Inc.FutureCeuticals, Inc. is a vertically integrated functional food ingredient, product development, and bioanalytical research and discovery company with farms and facilities in Illinois, Indiana, Wisconsin, California, and Europe.
CONTACT: Andrew Wheeler, awheeler@futureceuticals.com
No comments:
Post a Comment
id="blogfeeds"><$BlogFeedsVertical$>
id="postfeeds"><$BlogItemFeedLinks$>